Page last updated: 2024-09-04

levofloxacin and Diabetes Mellitus

levofloxacin has been researched along with Diabetes Mellitus in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Elberry, AA; Hussein, RRS; Saad, NA; Samy Matar, H	1
Huntington, JA; Long, J; Popejoy, MW	1
Adebola, SO; Adedeji, TO; Adefuye, BO; Oladeji, SM; Sogebi, OA	1

Trials

2 trial(s) available for levofloxacin and Diabetes Mellitus

Article	Year
Effect of ciprofloxacin vs levofloxacin on QTc-interval and dysglycemia in diabetic and non-diabetic patients. International journal of clinical practice, 2021, Volume: 75, Issue:5 Topics: Adult; Ciprofloxacin; Diabetes Mellitus; Fluoroquinolones; Humans; Levofloxacin; Prospective Studies	2021
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam. BMC infectious diseases, 2017, 05-02, Volume: 17, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intraabdominal Infections; Levofloxacin; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections	2017

Article

Year

Effect of ciprofloxacin vs levofloxacin on QTc-interval and dysglycemia in diabetic and non-diabetic patients.

International journal of clinical practice, 2021, Volume: 75, Issue:5

Topics: Adult; Ciprofloxacin; Diabetes Mellitus; Fluoroquinolones; Humans; Levofloxacin; Prospective Studies

2021

Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.

BMC infectious diseases, 2017, 05-02, Volume: 17, Issue:1

Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intraabdominal Infections; Levofloxacin; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections

2017

Other Studies

2 other study(ies) available for levofloxacin and Diabetes Mellitus

Article	Year
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy. Auris, nasus, larynx, 2017, Volume: 44, Issue:4 Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; Coinfection; Comorbidity; Cycloserine; Diabetes Mellitus; Female; Hearing Loss; HIV Infections; Humans; Kanamycin; Levofloxacin; Male; Middle Aged; Nigeria; Prospective Studies; Prothionamide; Pyrazinamide; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult	2017
Levofloxacin and glycaemic disorders. Diabetic patients: beware. Prescrire international, 2008, Volume: 17, Issue:97 Topics: Canada; Diabetes Mellitus; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Ofloxacin	2008

Article

Year

Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.

Auris, nasus, larynx, 2017, Volume: 44, Issue:4

Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; Coinfection; Comorbidity; Cycloserine; Diabetes Mellitus; Female; Hearing Loss; HIV Infections; Humans; Kanamycin; Levofloxacin; Male; Middle Aged; Nigeria; Prospective Studies; Prothionamide; Pyrazinamide; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult

2017

Levofloxacin and glycaemic disorders. Diabetic patients: beware.

Prescrire international, 2008, Volume: 17, Issue:97

Topics: Canada; Diabetes Mellitus; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Ofloxacin

2008